The image quality for detecting prostate cancer is significantly better for MRI at 1.5 T using an endorectal-body phased-array coil as compared with the 3.0 T imaging using the torso phased-array coil ...

The purpose of this study is to report our method in detecting prostate cancer (PCa) using an 18-core transrectal ultrasound (TRUS) prostate biopsy (PB) schema, in combination with additional targeted ...

Influence of vascular comorbities and race on erectile dysfunction after prostate cancer radiotherapy. Background: One troubling aspect of active surveillance (AS) is that a subset of patients ...

Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. The accuracy of erMRI to ...

August 15, 2006 — The US Food and Drug Administration (FDA) has approved a tumor localization system for adjunctive use in patients undergoing prostate cancer radiation therapy; an endorectal coil for ...

November 30, 2006 (Chicago) -- Magnetic resonance spectroscopic imaging (MRSI) shows no advantages over magnetic resonance imaging (MRI) alone for localization of peripheral zone prostate cancer in ...

The National Cancer Institute (NCI), Center for Cancer Research (CCR) Genomics Core plans to procure Brand Name or Equal Bayer Healthcare BPX30 Disposable Endorectal Coils for 3.0T MRI Scanner. This ...

The National Cancer Institute (NCI), Center for Cancer Research (CCR) Genomics Core plans to procure Brand Name or Equal Bayer Healthcare BPX30 Disposable Endorectal Coils for 3.0T MRI Scanner. This ...